Targeted Therapy for Melanoma: A Primer
- 1 January 2011
- journal article
- review article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 20 (1) , 165-180
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAFNature, 2010
- The dual PI3K/mTOR inhibitor PI‐103 promotes immunosuppression, in vivo tumor growth and increases survival of sorafenib‐treated melanoma cellsInternational Journal of Cancer, 2010
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAFCell, 2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human CancerCancer Cell, 2009
- Frequencies of NRAS and BRAF Mutations Increase from the Radial to the Vertical Growth Phase in Cutaneous MelanomaJournal of Investigative Dermatology, 2009
- BrafV600E cooperates with Pten loss to induce metastatic melanomaNature Genetics, 2009
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- Mutations of the BRAF gene in human cancerNature, 2002